SG Americas Securities
SLS icon

SG Americas Securities’s SELLAS Life Sciences SLS Stock Holding History

SG Americas Securities’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64K Sell
15,166
-21,284
-58% -$95.2K ﹤0.01% 3006
2025
Q4 		$137K Buy
36,450
+17,084
+88% +$33.2K ﹤0.01% 3089
2025
Q3 		$31K Sell
19,366
-1,544
-7% -$2.75K ﹤0.01% 3248
2025
Q2 		$46K Buy
+20,910
New +$32.1K ﹤0.01% 2769
2017
Q2 		– Sell
-84
Closed -$77K – 3477
2017
Q1 		$77K Buy
84
+66
+367% +$109K ﹤0.01% 3051
2016
Q4 		$51K Buy
+18
New +$105K ﹤0.01% 2933

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

SG Americas Securities's SLS Position: Q1 2026 in Review

SG Americas Securities reduced its SELLAS Life Sciences (SLS) stake by 58% in Q1 2026, selling an estimated $95.2K and leaving 15,166 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #3006.

SG Americas Securities first reported a position in SLS in Q4 2016 and has held it in 6 quarters since. The position peaked at $137K in Q4 2025. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • SG Americas Securities held 15,166 shares of SELLAS Life Sciences worth $64K as of Q1 2026.
  • SG Americas Securities sold 21,284 SELLAS Life Sciences shares in Q1 2026, an estimated $95.2K.
  • SELLAS Life Sciences made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #3006 holding.
  • SG Americas Securities first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 6 quarters since.
  • SG Americas Securities's SELLAS Life Sciences position peaked at $137K in Q4 2025.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.